In contrast to COL3A1 expression, the risk model did not represent the actual immue situation of HNSCC lesions as high‐risk patients exhibited elevated TNFRSF25 levels relative to low‐risk patients. This evidence concerns the gene COL3A1 and head and neck squamous cell carcinoma.